arrow
M

Mahdi Behdani

pasteur institute of iran
H指数:26
被引数:2,209

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Computational prioritization of RBD-targeting nanobodies across SARS-CoV-2 Omicron sublineages, followed by rational biparatopic design and targeted experimental validation

SARS-CoV-2奥密克戎亚谱系中RBD靶向纳米抗体的计算优先级排序,随后进行理性双表位设计及靶向实验验证

2026-07-010
PRE
Ocular Safety of Intravitreal Engineered Humanized Anti-VEGF Nanobody and Its Efficacy in the Attenuation of Choroidal Neovascularization and Associated Subretinal Fibrosis

玻璃体内工程化人源化抗VEGF纳米抗体对眼的安全性及其在减轻脉络膜新生血管和相关的视网膜下纤维化中的疗效

2026-05-250
OA
Affinity enhancement of an anti-VEGF humanized nanobody as a superior candidate to bevacizumab: integrative in silico and in vitro studies

人源化抗VEGF纳米抗体的亲和力增强及其作为优于贝伐珠单抗候选物的整合体内外研究

2026-05-120
OAAI
Enhancement of lentiviral vectors gene delivery against VEGFR2 expressing cells by co-display of the binding and fusogenic moieties: a two molecules targeting approach

通过共展示结合和融合结构域实现针对VEGFR2表达细胞的慢病毒载体基因递送增强:一种双分子靶向策略

2025-09-290
OAAI